- Targeting MALT1 proteolytic activity in immunity, inflammation and disease: good or bad?
- Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis
- T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1
Cleavage by MALT1 induces cytosolic release of A20
2010) BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 400(4). p.543-547 Mark(